Secretory leukocyte protease inhibitor inhibits neutrophil apoptosis

Respirology

Volumn 16, Issue 2, 2011, Pages 300-307

  Subramaniyam, Devipriya ^a   Hollander, Camilla ^b   Westin, Ulla ^b   Erjefält, Jonas ^b   Stevens, Tim ^c   Janciauskiene, Sabina ^a  

^a HANNOVER MEDICAL SCHOOL   (Germany)

^b LUND UNIVERSITY   (Sweden)

^c ASTRAZENECA R AND D   (Sweden)

Author keywords

adhesion; apoptosis; chemotaxis; neutrophil; secretory leukocyte protease inhibitor

Indexed keywords

ENDOTOXIN; FIBRONECTIN; INTERLEUKIN 8; SECRETORY LEUKOCYTE PROTEINASE INHIBITOR;

ADULT; APOPTOSIS; ARTICLE; CELL ADHESION; CHRONIC OBSTRUCTIVE LUNG DISEASE; CLINICAL ARTICLE; DRUG ACTIVITY; DRUG BLOOD LEVEL; FEMALE; HUMAN; HUMAN TISSUE; IMMUNOREACTIVITY; IN VITRO STUDY; LUNG LAVAGE; MALE; NEUTROPHIL CHEMOTAXIS; NOSE PROVOCATION TEST; PRIORITY JOURNAL;

EID: 79551528410     PISSN: 13237799     EISSN: 14401843     Source Type: Journal    
DOI: 10.1111/j.1440-1843.2010.01901.x     Document Type: Article

References (38)

1. Hochstrasser K, Reichert R, Schwarz S, et al. Isolation and characterisation of a protease inhibitor from human bronchial secretion. Hoppe-Seyler's Z. Physiol. Chem. 1972; 353: 221-6.
2. Moriyama A, Shimoya K, Kawamoto A, et al. Secretory leukocyte protease inhibitor (SLP) concentrations in seminal plasma: SLPI restores sperm motility reduced by elastase. Mol. Hum. Reprod. 1998; 4: 946-50.
3. Moriyama A, Shimoya K, Ogata I, et al. Secretory leukocyte protease inhibitor (SLPI) concentrations in cervical mucus of women with normal menstrual cycle. Mol. Hum. Reprod. 1999; 5: 656-61.
4. Sathe S, Sakata M, Beaton AR, et al. Identification, origins and the diurnal role of the principal serine protease inhibitors in human tear fluid. Curr. Eye Res. 1998; 17: 348-62.
5. Shimoya K, Moriyama A, Ogata I, et al. Increased concentrations of secretory leukocyte protease inhibitor in peritoneal fluid of women with endometriosis. Mol. Hum. Reprod. 2000; 6: 829-34.
6. Thompson RC, Ohlsson K,. Isolation, properties, and complete amino acid sequence of human secretory leukocyte protease inhibitor, a potent inhibitor of leukocyte elastase. Proc. Natl. Acad. Sci. USA 1986; 83: 6692-6.
7. Abe T, Kobayashi N, Yoshimura K, et al. Expression of the secretory leukoprotease inhibitor gene in epithelial cells. J. Clin. Invest. 1991; 87: 2207-15.
8. Lee CH, Igarashi Y, Hohman RJ, et al. Distribution of secretory leukoprotease inhibitor in the human nasal airway. Am. Rev. Respir. Dis. 1993; 147: 710-16.
9. Mihaila A, Tremblay GM,. Human alveolar macrophages express elafin and secretory leukocyte protease inhibitor. Z. Naturforsch. C 2001; 56: 291-7.
10. Sallenave JM, Si Tahar M, Cox G, et al. Secretory leukocyte proteinase inhibitor is a major leukocyte elastase inhibitor in human neutrophils. J. Leukoc. Biol. 1997; 61: 695-702.
11. Sallenave JM, Shulmann J, Crossley J, et al. Regulation of secretory leukocyte proteinase inhibitor (SLPI) and elastase-specific inhibitor (ESI/elafin) in human airway epithelial cells by cytokines and neutrophilic enzymes. Am. J. Respir. Cell Mol. Biol. 1994; 11: 733-41.
12. Abbinante-Nissen JM, Simpson LG, Leikauf GD,. Neutrophil elastase increases secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am. J. Physiol. 1993; 265: 286-92.
13. Abbinante-Nissen JM, Simpson LG, Leikauf GD,. Corticosteroids increase secretory leukocyte protease inhibitor transcript levels in airway epithelial cells. Am. J. Physiol. 1995; 268: 601-6.
14. He Z, Bateman A,. Progranulin (granulin-epithelin precursor, PC-cell-derived growth factor, acrogranin) mediates tissue repair and tumorigenesis. J. Mol. Med. 2003; 81: 600-12.
15. Sallenave JM,. Antimicrobial activity of antiproteinases. Biochem. Soc. Trans. 2002; 300: 111-15.
16. McNeely TB, Dealy M, Dripps DJ, et al. Secretory leukocyte protease inhibitor: a human saliva protein exhibiting anti-human immunodeficiency virus 1 activity in vitro. J. Clin. Invest. 1995; 96: 456-64.
17. McNeely TB, Shugars DC, Rosendahl M, et al. Inhibition of human immunodeficiency virus type 1 infectivity by secretory leukocyte protease inhibitor occurs prior to viral reverse transcription. Blood 1997; 90: 1141-9.
18. Zhang Y, DeWitt DL, McNeely TB, et al. Secretory leukocyte protease inhibitor suppresses the production of monocyte prostaglandin H synthase-2, prostaglandin E2, and matrix metalloproteinases. J. Clin. Invest. 1997; 99: 894-900.
19. Lentsch AB, Czermak BJ, Bless NM, et al. Essential role of alveolar macrophages in intrapulmonary activation of NF-kappaB. Am. J. Respir. Cell Mol. Biol. 1999; 20: 692-8.
20. Song X, Zeng L, Jin W, et al. Secretory leukocyte protease inhibitor suppresses the inflammation and joint damage of bacterial cell wall-induced arthritis. J. Exp. Med. 1999; 190: 535-42.
21. Ashcroft GS, Lei K, Jin W, et al. Secretory leukocyte protease inhibitor mediates non-redundant functions necessary for normal wound healing. Nat. Med. 2000; 6: 1147-53.
22. King AE, Wheelhouse N, Cameron S, et al. Expression of secretory leukocyte protease inhibitor and elafin in human fallopian tube and in an in-vitro model of Chlamydia trachomatis infection. Hum. Reprod. 2009; 24: 679-86.
23. Taggart CC, Cryan SA, Weldon S, et al. Secretory leucoprotease inhibitor binds to NF-kappaB binding sites in monocytes and inhibits p65 binding. J. Exp. Med. 2005; 202: 1659-68.
24. Seto T, Takai T, Ebihara N, et al. SLPI prevents cytokine release in mite protease-exposed conjunctival epithelial cells. Biochem. Biophys. Res. Commun. 2009; 379: 681-5.
25. Wihl JA, Baumgarten CR, Petersson G,. Contralateral differences among biomarkers determined by a modified nasal lavage technique after unilateral antigen challenge. Allergy 1995; 50: 308-15.
26. Howard OM, Dong HF, Shirakawa AK, et al. LEC induces chemotaxis and adhesion by interacting with CCR1 and CCR8. Blood 2000; 96: 840-5.
27. Pongracz J, Webb P, Wang K, et al. Spontaneous neutrophil apoptosis involves caspase 3-mediated activation of protein kinase C-delta. J. Biol. Chem. 1999; 274: 37329-34.
28. Sallenave JM,. The role of secretory leukocyte proteinase inhibitor and elafin (elastase-specific inhibitor/skin-derived antileukoprotease) as alarm antiproteinases in inflammatory lung disease. Respir. Res. 2000; 1: 87-92.
29. Jin FY, Nathan C, Radzioch D, et al. Secretory leukocyte protease inhibitor: a macrophage product induced by and antagonistic to bacterial lipopolysaccharide. Cell 1997; 88: 417-26.
30. Grobmyer SR, Barie PS, Nathan CF, et al. Secretory leukocyte protease inhibitor, an inhibitor of neutrophil activation, is elevated in serum in human sepsis and experimental endotoxemia. Crit. Care Med. 2000; 28: 1276-82.
31. Nakamura A, Mori Y, Hagiwara K, et al. Increased susceptibility to LPS-induced endotoxin shock in secretory leukoprotease inhibitor (SLPI)-deficient mice. J. Exp. Med. 2003; 197: 669-74.
32. Ward PA, Lentsch AB,. Endogenous regulation of the acute inflammatory response. Mol. Cell Biochem. 2002; 234-235: 225-8.
33. Everard ML, Swarbrick A, Wrightham M, et al. Analysis of cells obtained by bronchial lavage of infants with respiratory syncytial virus infection. Arch. Dis. Child. 1994; 71: 428-32.
34. Jacobsen LC, Sorensen OE, Cowland JB, et al. The secretory leukocyte protease inhibitor (SLPI) and the secondary granule protein lactoferrin are synthesized in myelocytes, colocalize in subcellular fractions of neutrophils, and are coreleased by activated neutrophils. J. Leukoc. Biol. 2008; 83: 1155-64.
35. Grunberg K, Kuijpers EA, de Klerk EP, et al. Effects of experimental rhinovirus 16 infection on airway hyperresponsiveness to bradykinin in asthmatic subjects in vivo. Am. J. Respir. Crit. Care Med. 1997; 155: 833-8.
36. Teran LM, Johnston SL, Schroder JM, et al. Role of nasal interleukin-8 in neutrophil recruitment and activation in children with virus-induced asthma. Am. J. Respir. Crit. Care Med. 1997; 155: 1362-6.
37. Baggiolini M, Dewald B, Moser B,. Interleukin-8 and related chemotactic cytokinesa-CXC and CC chemokines. Adv. Immunol. 1994; 55: 97-179.
38. Cassatella MA,. Neutrophil-derived proteins: selling cytokines by the pound. Adv. Immunol. 1999; 73: 369-509.